Skip to main content
Log in

Liquorpheresis (CSF-filtration): An effective treatment in acute and chronic severe autoimmune polyradiculoneuritis (Guillain-Barré syndrome)

  • Original Articles
  • Published:
European Archives of Psychiatry and Clinical Neuroscience Aims and scope Submit manuscript

Summary

In recent years, plasmapheresis has become a well established treatment of acute and chronic polyradiculoneuritis (Guillain-Barré syndrome, GBS). Nervertheless, there are still non-responders and there are particular risks associated with this treatment. Despite all efforts, the duration of severe forms of Guillain-Barré syndrome is still considerable. Inflammation and demyelination start intrathecally. We therefore used liquorpheresis (cerebrospinal fluid filtration) as a new effective therapeutic approach. Our first patient, severely disabled with acute GBS, artificially ventilated, had undergone plasma exchange without effect. Plasma immunoadsorption led only to transient improvement. After several liquorphereses, the patient recovered completely. In three additional patients with acute and two with chronic GBS an improvement of clinical signs in close temporal relation to liquorpheresis was observed. Twice, liquorpheresis was combined with immunoadsorption of cerebrospinal fluid. Liquorpheresis was well tolerated in all cases. This procedure may be effective by eliminating humoral or cell-bound factors responsible for the onset or/and maintenance of inflammation. Further controlled studies are necessary and are in progress.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Besser R, Pfeifer B, Weilemann LS, Hopf HC (1986) Plasmapherese beim Guillain-Barré Syndrom. Med Klin 12:409–413

    Google Scholar 

  2. Brettle RP, Gross M, Legg NJ, Lockwood M, Pallis C (1978) Treatment of acute polyneuropathy by plasma exchange. Lancet II:1100

    Google Scholar 

  3. Brinkmeier H, Wollinsky KH, Rüdel R, Hülser P-J: unpublished data

  4. Dyck PJ, Daube J, O'Brien P, Pineda A, Low PA, Windebank AJ, Swanson C (1986) Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy. N Engl J Med 314:461–465

    Google Scholar 

  5. Ferner R, Barnett M, Hughes RAC (1987) Management of Guillain-Barré syndrome. Br J Hosp Med 12:525–530

    Google Scholar 

  6. Gross MLP, Thomas PK (1981) The treatment of chronic relapsing and chronic progressive idiopathic inflammatory polyneuropathy by plasma exchange. J Neurol Sci 52:69–78

    Google Scholar 

  7. Gruener G, Bosch EP, Strauss RG, Klugman M, Kimura J (1987) Prediction of early beneficial exchange in Guillain-Barré syndrome. Arch Neurol 44:295–298

    Google Scholar 

  8. Guillain-Barré syndrome Study Group (1985) Plasmapheresis and acute Guillain-Barré syndrome. Neurology 35:1096–1104

    Google Scholar 

  9. Hartung H-P, Schwenke CH, Bitter-Suermann D, Toyka K (1987) Guillain-Barré syndrome: activated complement components C3a and C5a in CSF. Neurology 37:1006–1009

    Google Scholar 

  10. Hughes RAC (1989) Immunotherapy in neurology. Curr Opin Neurol Neurosurg 2:186–190

    Google Scholar 

  11. Levy RL, Newkirk R, Ochoa J (1979) Treatment of chronic relapsing Guillain-Barré syndrome by plasma exchange. Lancet II:259–260

    Google Scholar 

  12. Nathan CF (1987) Secretory products of macrophages. J Clin Invest 79:319–326

    Google Scholar 

  13. Ostermann PO, Fagius J, Säfwenberg J, Danersund A, Wallin BG, Nordesjö LO (1982) Treatment of the Guillain-Barré syndrome by plasmapheresis. Arch Neurol 39:148–154

    Google Scholar 

  14. Pollard JD (1987) A critical review of therapies in acute and chronic inflammatory demyelinating polyneuropathies. Nuscle Nerve 10:214–221

    Google Scholar 

  15. Sanders ME, Koski CL, Robbins D, Shin ML, Fank MM, Joiner KA (1986) Activated terminal complement in cerebrospinal fluid in Guillain-Barré syndrome and multiple sclerosis. J Immunol 136:4456–4459

    Google Scholar 

  16. Server AC, Lefkowith J, Braine H, McKhan GM (1979) Treatment of chronic relapsing inflammatory polyradiculoneuropathy by plasma exchange. Ann Neurol 6:258–261

    Google Scholar 

  17. Wiethölter H (1989) Verlaufsformen der experimentell- allergischen Neuritis. Elektrophysiologische Untersuchungen und Behandlung durch Plasmaseparation. In: Bauer HJ, Baumgartner G, Davison AN, Gänshirt H, (Eds) Schriftenreihe Neurologie, part 31, Springer, Berlin Heidelberg New York Paris Tokyo

    Google Scholar 

  18. Wiethölter H, Hülser P-J, Linington C, Meier CH, Wessel K (1988) Electrophysiological follow-up of experimental allergic neuritis, mediated by permanent T-cell line in rats. J Neurol Sci 83:1–14

    Google Scholar 

  19. Wollinsky KH, Mehrkens H-H, Hülser P-J, Weindler M, Geiger P, Matzek N, Kornhuber HH (1989) Liquorpherese, Liquorfiltration als neues Therapieverfahren bei der Behandlung eines schweren Guillain-Barré Syndroms. Anaesthesist 38 Supplement 1:630

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wollinsky, K.H., Weindler, M., Hülser, P.J. et al. Liquorpheresis (CSF-filtration): An effective treatment in acute and chronic severe autoimmune polyradiculoneuritis (Guillain-Barré syndrome). Eur Arch Psychiatry Clin Nuerosci 241, 73–76 (1991). https://doi.org/10.1007/BF02191143

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02191143

Key words

Navigation